Skip to main content
Log in

Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

5-Hydroxytryptamine (5 HT)-induced contractions were investigated on cocaine-treated strips of bovine large coronary arteries.

  1. 1.

    The α2-adrenoceptor blockers rauwolscine and yohimbine antagonized competitively 5 HT-induced contractions. The estimated equilibrium dissociation constantsK B (−log mol/l) were 7.1 for rauwolscine and 7.3 for yohimbine. The affinity of yohimbine for the receptors mediating the response to 5HT appears to be 10 times higher than for postsynaptic α1-adrenoceptor but 10 times lower than for postsynaptic vascular α2-adrenoceptor.

  2. 2.

    (−)-Noradrenaline and the α2-adrenoceptor agonist B-HT 920 caused maximum contractions amounting to only 20% and 2%, respectively, of the maximum 5 HT effects. Neither 60 μmol/l B-HT 920 nor 1 μmol/l prazosin antagonized the 5 HT effect.

  3. 3.

    Ketanserin was a competitive antagonist (K B=9.2 (−log mol/l)) of the effects of 5 HT. Combinations of rauwolscine or yohimbine with ketanserin antagonized the 5 HT effects as expected from competition of the 4 drugs for a single class of receptor.

  4. 4.

    The evidence is consistent with an interaction of 5 HT, ketanserin, rauwolscine and yohimbine with 5 HT2 receptors. α-Adrenoceptors only play a minor role in large coronary arteries and appear not to be involved in the 5 HT-induced contractions. A possible clinical involvement of 5 HT in coronary artery spasm is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonism. Br J Pharmacol 14:48–58

    Google Scholar 

  • Awouters F, Leysen JE, De Clerck F, van Nueten JM (1982) General pharmacological profile of ketanserin (R 41468), a selective 5-HT2 receptor antagonist. In: De Clerck F, Vanhoutte PM (eds) 5-Hydroxytryptamine in peripheral reactions. Raven Press, New York, pp. 193–197

    Google Scholar 

  • Blinks JR (1965) Convenient apparatus for recording contractions of isolated muscle. J Appl Physiol 20:755–757

    Google Scholar 

  • Brazenor RM, Angus JA (1981) Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: No role for alpha adrenoceptors. J Pharmacol Exp Ther 218:530–536

    Google Scholar 

  • Brazenor RM, Angus JA (1982) Actions of serotonin antagonists on dog coronary artery. Eur J Pharmacol 81:569–576

    Google Scholar 

  • Consolazione A, Milstein C, Wright B, Cuello AC (1981) Immunocytochemical detection of serotonin with monoclonal antibodies. J Histochem Cytochem 29:1425–1430

    Google Scholar 

  • Constantine JW, Lebel W, Archer R (1982) Functional postsynaptic β but not α1-adrenoceptor in dog saphenous vein exposed to phenoxybenzamine. Eur J Pharmacol 85:325–329

    Google Scholar 

  • De Mey J, Vanhoutte PM (1981) Uneven distribution of postjunctional alpha1- and alpha2-like adrenoceptors in canine arterial and venous smooth muscle. Circ Res 48:875–884

    Google Scholar 

  • Feniuk W, Humphrey PPA, Watts AD (1981) Further characterization of pre- and post-junctional receptor for 5-hydroxytryptamine in isolated vasculature. Br J Pharmacol 73:191P-192P

    Google Scholar 

  • Gaddum JH, Picarelli ZP (1957) Two kinds of tryptamine receptor. Br Pharmacol 12:323–328

    Google Scholar 

  • Holtz J, Saeed M, Sommer O, Bassenge E (1982) Norepinephrine constricts the canine coronary bed via postsynaptic α2-adrenoceptor. Eur J Pharmacol 82:199–202

    Google Scholar 

  • Innes IR (1962) An action of 5-hydroxytryptamine on adrenaline receptors. Br J Pharmacol 19:427–442

    Google Scholar 

  • Kaumann AJ (1982) Yohimbine, rauwolscine and ketanserin antagonize 5HT contractures through the same receptors in large coronary arteries of calf. Pflügers Arch 394:R89

    Google Scholar 

  • Kaumann AJ, Mc Inerny T, Gilmour DP, Blinks JR (1980) Comparative assessment of β-receptor blocking agents as simple competitive antagonists in isolated heart muscle. Similarity of inotropic and chronotropic blocking potencies against isoproterenol. Naunyn-Schmiedeberg's Arch Pharmacol 311:219–236

    Google Scholar 

  • Kaumann AJ, Breuer H-WM, Arnold G (1982) Heterogeneous spare receptors for serotonin (5HT) in bovine coronary arteries. Pflügers Arch 392:R36

    Google Scholar 

  • Lambert GA, Lang WJ, Friedman E, Meller E, Gershon S (1978) Pharmacological and biochemical properties of isomeric yohimbine alkaloids. Eur J Pharmacol 49:39–48

    Google Scholar 

  • Lemoine H, Kaumann AJ (1982) A novel analysis of concentration-dependence of partial agonism. Ring-demethylation of bupranolol results in a high-affinity partial agonist (K 105) for myocardial and tracheal β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 320:130–144

    Google Scholar 

  • Lemoine H, Kaumann AJ (1983) A model for the interaction of antagonists with two receptor-subtypes characterized by a Schildplot with apparent slope unity. Agonist-dependent enantiomeric affinity ratios for bupranolol in trachae but not in right atria of guinea pigs. Naunyn-Schmiedeberg's Arch Pharmacol 322:111–120

    Google Scholar 

  • Leysen JE, Awouters F, Kenis L, Laduron PM, Vandenberg J, Janssen PAJ (1981) Receptor binding profile of R 41468, a novel antagonist at 5HT2 receptors. Life Sci 28:1015–1022

    Google Scholar 

  • Leysen JE, Niemegeers CJE, van Nueten JM, Laduron PM (1982) [3H]Ketanserin (R 41468), a selective3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol Pharmacol 21:301–314

    Google Scholar 

  • Lues I, Schümann HJ (1982) Characterization of postsynaptic α-adrenoceptors in the isolated saphenous vein of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 321:R65

    Google Scholar 

  • Mena MA, Vidrio H (1976) On the mechanism of the coronary dilator effect of serotonin in the dog. Eur J Pharmacol 36:1–5

    Google Scholar 

  • Morris TH, Sandrock K, Kaumann AJ (1981)3H-(−)-bupranolol (3H-Bu), a new β-adrenoceptor radioligand: Binding to cat heart β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 317:19–25

    Google Scholar 

  • Nickerson M (1971) Drugs inhibiting adrenergic nerves and structures innervated by them. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 4th edition. Collier-MacMillan, pp 549–584

  • Paton WDM, Rand HP (1965) The uptake of atropine and related drugs by intestinal smooth muscle of the guinea-pig in relation to acetylcholine receptors. Proc Roy Soc Ser B (London) 163:1–44

    Google Scholar 

  • Peroutka ST, Snyder SH (1979) Multiple serotonin receptors: Differential binding of (3H)5-hydroxytryptamine, (3H)lysergic acid diethylamine and (3H)spiroperidol. Mol Pharmacol 16:687–699

    Google Scholar 

  • Porquet M-F, Pourrias B, Santamaria R (1982) Effects of 5-hydroxytryptamine on canine isolated coronary arteries. Br J Pharmacol 75:305–310

    Google Scholar 

  • Shepperson NB, Langer SZ (1981) The effects of the 2-amino-tetrahydronaphthalene derivative M7, a selective α2-adrenoceptor in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 318:10–13

    Google Scholar 

  • Snipes RL, Thoenen H, Tanzer JP (1968) Fine structure localization of exogeneous 5-HT in vesicles of adrenergic nerve terminals. Experientia (Basel) 24:1026–1027

    Google Scholar 

  • Starke K (1981) α-adrenoceptor subclassification. Rev Physiol Biochem Pharmacol 88:199–235

    Google Scholar 

  • Thoa NB, Eccleston D, Axelrod J (1969) The accumulation of14C-serotonin in the guinea-pig vas deferens. J Pharmacol Exp Ther 169:68–73

    Google Scholar 

  • Timmermans PBMWM, de Jonge A, van Meel JCA, Slothorst-Grisdijk FP, Lam E, van Zwieten PA (1981) Characterization of α-adrenoceptor populations. Quantitative relationships between cardiovascular effects initiated at central and peripheral α-adrenoceptors. J Med Chem 24:502–507

    Google Scholar 

  • Van Meel JCA, de Jonge A, Kalkman HO, Wilffert B, Timmermans PBMWM, van Zwieten PA (1981) Vascular smooth muscle contraction initiated by postsynaptic α-adrenoceptor activations is induced by an influx of extracellular calcium. Eur J Pharmacol 69:205–212

    Google Scholar 

  • Van Nueten JM, Janssen PAJ, van Beek J, Xhonneux R, Verbeuren TJ, Vanhoutte PM (1981) Vascular effects of ketanserin (R 41468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther 218:217–230

    Google Scholar 

  • Weitzell R, Tanaka T, Starke K (1979) Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 308:127–136

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaumann, A.J. Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 323, 149–154 (1983). https://doi.org/10.1007/BF00634263

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00634263

Key words

Navigation